After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Soleno Therapeutics Inc is $2.20B. A total of 0.52 million shares were traded on the day, compared to an average of 582.91K shares.
In the most recent transaction, Yen Kristen sold 2,520 shares of SLNO for 45.41 per share on Jan 02 ’25. After the transaction, the insider now owns 78,945 company shares. In a previous transaction on Jan 03 ’25, Yen Kristen sold 2,340 shares at 46.18 per share. SLNO shares that the insider owns now total 76,605.
Among the insiders who sold shares, Mackaness James H disposed of 4,083 shares on Jan 02 ’25 at a per-share price of $45.41. This resulted in the CHIEF FINANCIAL OFFICER holding 115,089 shares of SLNO after the transaction. In another insider transaction, Mackaness James H sold 3,791 shares at $46.18 per share on Jan 03 ’25. Company shares held by the CHIEF FINANCIAL OFFICER now total 111,298.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, SLNO has a high of $60.92 and a low of $36.61.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. SLNO’s latest balance sheet shows that the firm has $21.30M in Cash & Short Term Investments as of fiscal 2021. There were $457.00k in debt and $8.01M in liabilities at the time. Its Book Value Per Share was $6.45, while its Total Shareholder’s Equity was $17.79M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLNO is Buy with a score of 5.00.
